Carberry hits ton on return after cancer treatment


Carberry hits ton on return after cancer treatment

Cricbuzz Staff • Last updated on Sun, 02 Apr, 2017, 10:23 PM

Michael Carberry received a standing ovation from the Ageas Bowl crowd © Getty

Hampshire opener Michael Carberry marked his return to cricket with a century against Cardiff MCCU at the Ageas Bowl on Sunday (April 2). The left-handed batsman, who has played six Tests for England, was diagnosed with a cancerous tumour last July and missed the second half of last season.

Carberry, who returned to cricket after a successful treatment, was given a standing ovation by the crowd after he was dismissed by David O’Sullivan, but not before scoring a 121-ball 100. His innings helped Hampshire post 289 in the first innings, before reducing the opposition to 21 for 2 at Stumps on the opening day.

In an official statement last week, the left-hander had said, “I would like to thank my family, the club, the supporters and my team-mates worldwide for all the kind messages of support and love through another very tough time in my career and life.

“There is still a long way to go to being ‘recovered’ fully, but the outpouring of support from the cricket family has helped massively in getting me back playing and I’m looking forward to another great summer with Hampshire.

“In regards to the media, I would like to thank them for respecting my privacy in dealing with my illness and I would like to ask for this to continue on my return.”

© Cricbuzz



WHO estimates suggest 300 million people suffer from depression

(Representational) (Representational)

More than 300 million people are living with depression, according to the latest estimates from the World Health Organisation (WHO). The UN agency released the estimates on Thursday ahead of World Health Day. “These new figures are a wake-up call for all countries to re-think their approaches to mental health and to treat it with the urgency that it deserves,” Xinhua news agency quoted a WHO news release as saying. With the number of people with depression increasing more than 18 per cent from 2005 to 2015, WHO is carrying out a year-long campaign, Depression: Let’s Talk, the focus of April 7’s World Health Day, with the aim of encouraging more people with depression to get help.

Lack of support for people with mental disorders, coupled with a fear of stigma, prevent many from accessing the treatment they need to live healthy, productive lives. Depression is an important risk factor for suicide, which claims hundreds of thousands of lives each year, says the report. One of the first steps is to address issues around prejudice and discrimination.

“The continuing stigma associated with mental illness was the reason why we decided to name our campaign Depression: let’s talk,” said Shekhar Saxena, Director of the Department of Mental Health and Substance Abuse at WHO. “For someone living with depression, talking to a person they trust is often the first step towards treatment and recovery.”

Increased investment is also needed. In many countries, there is no, or very little, support available for people with mental health disorders. Even in high-income countries, nearly 50 per cent of people with depression do not get treatment. On average, just three per cent of government health budgets is invested in mental health, varying from less than one percent in low-income countries to five percent in high-income countries, says the report.

For all the latest Lifestyle News, download Indian Express App now


Enquiry ordered after complaints of suspected food poisoning at CRPF camp in Kerala, 109 jawans under observation

(Representational) (Representational)

An enquiry has been ordered after complaints of suspected food poisoning at a CRPF camp in Kerala, news agency ANI reported. At least 400 jawans at the camp in Pallipuram in state capital Thiruvananthapuram started vomiting and complained of stomach ache after consuming food Saturday night. While many of them were admitted to hospitals in the city, 109 jawans are said to be under observation at the Trivandrum medical college hospital.

Health Minister Shylaja visited the jawans in hospital and took stock of the situation.

“The condition of four was a bit serious when they arrived here, but they have quickly responded to the treatment,” the hospital superintendent told IANS.

For all the latest India News, download Indian Express App now

© IE Online Media Services Pvt Ltd


Why TB is still with us

It kills an estimated 4,80,000 Indians each year — more than 1,400 every day, almost one Indian per minute. It kills an estimated 4,80,000 Indians each year — more than 1,400 every day, almost one Indian per minute.

Having worked in community health for over two decades in Bihar and Madhya Pradesh, I am well aware of the power of the slogan. Especially of one so simple and telling: TB Harega, Desh Jeetega. And yet, this rang hollow as we marked another TB Day on March 24. The disease is far from being vanquished. It kills an estimated 4,80,000 Indians each year — more than 1,400 every day, almost one Indian per minute.

The startling fact is that this number creates little panic in the public. It doesn’t get any headline attention at a time when everything is a headline — when was the last time you heard a debate in Parliament or on prime time TV on TB? The toll hasn’t reached this figure overnight or in a month or even in a year. India has continued to account for one fourth of the global TB burden for more than a decade despite implementing the WHO-backed Directly Observed Treatment, Short-Course (DOTS) programme nationwide.

Indeed, India is the largest DOTS implementing country and the Revised National Tuberculosis Control Programme (RNTCP) under the leadership of Central Tuberculosis Division, a wing of the Union Ministry of Health and Family Welfare, has been praised internationally.

Recently, the government made three significant important policy decisions to improve disease surveillance: Making TB a notifiable disease (May 2012); including anti-TB drugs under Schedule-H1 (August 2013); and developing a case-based, web-based TB surveillance system.

So why is the disease still with us despite the above and the fact that its causative organism is known, effective drugs are available and key locations of the vulnerable population are well mapped? There are many reasons but let’s focus on one that doesn’t get discussed much: The public-private trust deficit.

Over 80 per cent of people with TB first knock on the doors of the private health sector where the standard of diagnosis and quality of TB care have always been contentious issues. As per norms, a private doctor or hospital has to inform the government about each TB case but this hardly happens. There is a deep trust deficit between the public and the private sector but it’s deeper when it comes to TB. It would be unfair to pass the entire blame for not notifying on private doctors. There is an undue expectation from private providers that they will follow the DOTS administration to ensure treatment adherence. There is no institutionalised mechanism to help them update their knowledge and skills about changing diagnostic algorithms, even the use of anti-TB drugs in appropriate doses for the correct duration.

A study by Zarir F. Udwadia and others to understand the prescribing practices of private practitioners in Mumbai found that the practitioners were never approached or oriented by the local TB programme. Only six of the 106 respondents wrote a prescription with a correct drug regimen. And the 106 doctors prescribed 63 different drug regimens. Wherever those barriers have been addressed, the notification has significantly improved. For example, in Patna, where private doctors have been engaged through a private-provider interface agency, notification has increased fourfold.

Although there have always been provisions for the involvement of NGOs and private practitioners in the government’s anti-TB programmes, the state and district-level programme managers themselves were never adequately oriented towards facilitating the partnership.

RNTCP has an “intermittent drug regimen” (three days of drugs a week). Outside RNTCP, the most common treatment method is the daily drug regimen. Healthcare providers, particularly in the private sector, have always had reservations in engaging with the RNTCP due to a lack of confidence in an intermittent regimen.

That’s changing. The treatment of TB with a daily regimen, under RNTCP, is being implemented for all HIV-infected TB patients across the country and for all TB patients in Kerala, Maharashtara, Bihar, Himachal Pradesh and Sikkim. It is likely to be made available across the country in the near future. This will likely to enhance notification from private sector.

One reason why notification is so important is because TB comes wrapped in silence and invisibility. Anyone, rich or poor, can get infected with the TB bacteria and already more than 40 per cent of the Indian population is said to harbour it. But over 90 per cent of such people (infected) may not fall ill because of TB or spread the disease. This will depend on their immune system, standard of nutrition, the condition of their overall health and their habitat. So, in cases where the patient is well-placed, the bacteria may remain alive inside the body for a lifetime without producing any symptoms. It is the poor and the marginalised who are the first victims.

That’s why the key to the fight against TB is how ministries other than the health ministry respond to the Sustainable Development Goals.

Prevention, care and support to TB-affected people will contribute to other SDGs and will help all, particularly the poor and the vulnerable who have to pay a catastrophic cost due to the disease — debt, loss of wages and death. At the rate of almost one a minute.

For all the latest India News, download Indian Express App now


Sane lawmaking; now to make it work

In an instance of rare non-partisan lawmaking, Parliament passed the Mental Healthcare Bill protecting the rights of persons with mental illness, and providing access to mental healthcare. The legislation also decriminalises suicide, recognising that attempts at taking one’s life are usually rooted in mental illness.

The law makes it clear that mental illness is an illness, not an abnormality that detracts from their integral worth. Patient consent and confidentiality, access to medical records, the advance right to determine the course of treatment during a mental health situation, and the right to nominate a representative are enshrined in the law. It provides protection against discrimination, the right to equality of treatment, a say in the course of their treatment, and from inhuman and degrading treatment such as forced sterilisation, confinement and chaining, free legal services, and the right to complain of deficient care. The Bill makes insurance cover mental illness. This is welcome, but it needs to be ensured that insurers do not deny the mentally ill coverage for physical illnesses.

Much has been said about the rights-based approach of the Mental Healthcare Bill. What is central to persons with mental illness and their families is the ability to access professional, affordable and quality treatment. Implementation of this law is likely to be hampered by the acute shortage of mental health professionals. Rough estimates suggest that 2.5 crore to 6.25 crore persons suffer from mental illness. India has 4,000 trained psychiatrists, against a conservative requirement of 12,500. Psychiatric nurses number 3,000, and clinical psychologists, 2,000. The government must now take the necessary measures to ensure that the legislation is implemented.


Doctors detect gene mutation responsible for Eman’s obesity

A detailed gene analysis on Eman Ahmed, the Egyptian woman undergoing weight loss treatment in Mumbai, has assigned as the cause of her obesity a rare mutation in the LEPR gene. Doctors have detected “homozygous missense variant” in the gene, a condition they claim has been seen for the first time causing obesity.

The genome analysis, done with assistance of US-based experts and Core Diagnostics, studied 91 different genes that are usually responsible for obesity. The 36-year-old woman, who weighed an estimated 500 kg on her arrival in India in February, has already undergone a bariatric surgery and shed over 160 kg.

She currently weighs 340 kg. Last week, doctors at Saifee Hospital claimed she was able to prop herself up on the bed without any external support, though other medical issues continue to trouble her, including paralysis, kidney ailment, diabetes, hypertension and insomnia.

Her current diagnosis shows she suffers from leptin receptor deficiency owing to the gene mutation. Due to this, the brain signals for a sense of hunger and satiety are disrupted causing excessive food intake and mounting weight. In Eman’s case, since her early life her brain has perceived she is constantly starving.

The gene results have brought both clarity and difficulty in assessing her future treatment, admits the team of over 16 doctors treating her.

Bariatric surgeon Dr Muffadal Lakdawala says there is no definitive treatment for such a gene disorder. “The operation that she recently underwent may have some beneficial effects but does not deal with the underlying problem. New drugs are being developed, which may have some promise in this situation, but it is very early days for these drugs,” he says.

According to bariatric surgeon Aparna Bhasker, surgery is still required in Eman’s case as drugs will not be able to alone treat obesity. Her rapid weight reduction till now has been because of fluid reduction in her body based on a controlled diet. Beyond that, chances of regaining weight are always high, say doctors.

The Egyptian national is currently on a high-protein diet, getting fed soya milk and protein powder after every two hours. In a day, her food intake is limited to 1,800 calories.

“She has done extremely well post surgery but continues to remain on tube feeds because of a difficulty in swallowing fluids because of a previously suffered stroke,” says a doctor, adding that physiotherapy is on to make her fit enough to fly back home.

“Later, she may need a more radical surgery, which has chances of causing malabsorption,” says Lakdawala. Malabsorption is a disorder in which intestine cannot absorb enough nutrients the disorder is sometimes triggered by bariatric procedures.

Eman got restricted to her home in Alexandria (Egypt) at the age of 11 when she quit school due to growing weight. Two years ago, obesity made her bed-ridden relying heavily on her mother and sister for bathing and eating.

For all the latest India News, download Indian Express App now

© IE Online Media Services Pvt Ltd


Sara death case: ‘CM has asked me to meet him’

Independent MLA Amanmani Tripathi’s mother-in-law Seema Singh on Wednesday claimed that she was invited to meet Chief Minister Yogi Adityanath on Thursday.

Amanmani is accused of allegedly killing his wife Sara in 2015. Two days ago, Seema, along with Nidhi Shukla, whose sister Madhumita Shukla was murdered by Amanmani’s parents, had asked the BJP not to induct him into the party as they feared he could then influence the CBI.

“I got a call from Chief Minister’s office this morning that the CM wanted to speak to me. He has asked me to meet him at his official residence at 5, Kalidas Marg on Thursday at 9 am,” Seema Singh told The Indian Express. No government official could confirm the development.

Asked about the issues that she would raise before Chief Minister, she alleged, “Amarmani (Amanmani’s father) and Amanmani had links with the Samajwadi Party leaders and now want to develop relations with BJP leaders as well. I fear that this might affect CBI investigation into Sara’s murder case. I would request Chief Minister to first ensure that Amarmani stops getting special treatment at the Gorakhpur jail where he is lodged.”

“Secondly, I would also request a special committee to look into the role played by SP leaders and also officers in Sara’s murder case at the time (when they were in government) and also that how come both Amarmani and his wife managed to stay at Gorakhpur Medical College in the name of treatment for such a long time,” she added. “We would also request for security to be given to our family as there is a constant threat on us.”

She further said that apart from seeking inquiry into the alleged “disproportionate assets” of both Amarmani and his son, she would also seek inquiry against doctors in Firozabad for allegedly giving “wrong postmortem report into Sara’s death”. She maintained that she would also approach Supreme Court against the bail given to Amanmani Tripathi by Allahabad High Court earlier on March 9 this year.

For all the latest India News, download Indian Express App now

© IE Online Media Services Pvt Ltd


Stem cells from fat injected in penis help men overcome erectile issues

There are several medical conditions which can take a toll on people’s sex lives and might even leave them unable to have sex. But medical technology seems to be helping several individuals, be it a man who got a bionic penis after losing his member in an accident or an injection that can increase penis size by two inches.

Now a new method has been introduced as a treatment for long term impotency in men, and it involves fat from the body being used for good. The procedure involves taking stem cells from fat in the body and injecting them in the penis to help men regain spontaneous erections with medicines or implants.

A large number of men were able to have penetrative sex thanks to this treatment including a man diagnosed for prostate cancer. Men who had no effect from medication earlier were able to retain erection for a year.

A large number of men are facing erectile dysfunction since around 40 percent men do struggle with it till the age of 40.